Amgen pleaded guilty and paid $762 million over illegal drug marketing and False Claims Act allegations
Company: Amgen Inc.
Summary
Amgen pleaded guilty to introducing misbranded Aranesp into interstate commerce and agreed to a $762 million global criminal and civil resolution. DOJ said the civil component also resolved allegations involving off-label promotion, kickbacks and false price reporting. Source: https://www.justice.gov/archives/opa/pr/amgen-inc-pleads-guilty-federal-charge-brooklyn-ny-pays-762-million-resolve-criminal